SV LIFE Sciences FUND Iv, L.P., 10% Owner at KalVista Pharmaceuticals, Inc. (KALV), sold 98,620 shares at $29.40 ($2.9M) on 2019-04-10, disclosed to the SEC on 2019-04-10.
Open-market sale of $2.9M KALV by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $29.49 | 629 | $19K | 0.6% |
| 2 | $29.49 | 22,171 | $654K | 22.7% |
| 3 | $29.49 | 22,171 | $654K | 22.7% |
| 4 | $28.53 | 377 | $11K | 0.4% |
| 5 | $28.53 | 13,292 | $379K | 13.2% |
| 6 | $28.53 | 13,292 |
| $379K |
| 13.2% |
| 7 | $29.40 | 374 | $11K | 0.4% |
| 8 | $29.40 | 13,157 | $387K | 13.4% |
| 9 | $29.40 | 13,157 | $387K | 13.4% |
| Total | $29.20 avg | 98,620 | $2.9M | 100% |
| Filing → |